GYRE THERAPEUTICS, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Gyre Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Gyre Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 101 %, a 46.2% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 101 -86.4 -46.2% Jun 30, 2024
Q1 2024 532 +508 +2124% Mar 31, 2024
Q4 2023 -95.1 -113 -634% Dec 31, 2023
Q3 2023 -459 -478 -2505% Sep 30, 2023
Q2 2023 187 +163 +680% Jun 30, 2023
Q1 2023 23.9 -5.14 -17.7% Mar 31, 2023
Q4 2022 17.8 -4.19 -19.1% Dec 31, 2022
Q3 2022 19.1 -1.82 -8.7% Sep 30, 2022
Q2 2022 24 +5.02 +26.5% Jun 30, 2022
Q1 2022 29.1 +11.8 +68% Mar 31, 2022
Q4 2021 22 +4.91 +28.8% Dec 31, 2021
Q3 2021 20.9 +0.38 +1.85% Sep 30, 2021
Q2 2021 19 -0.28 -1.46% Jun 30, 2021
Q1 2021 17.3 -0.8 -4.42% Mar 31, 2021
Q4 2020 17.1 +1.42 +9.07% Dec 31, 2020
Q3 2020 20.5 +13.2 +180% Sep 30, 2020
Q2 2020 19.2 +14.3 +288% Jun 30, 2020
Q1 2020 18.1 +14.6 +422% Mar 31, 2020
Q4 2019 15.7 +13 +490% Dec 31, 2019
Q3 2019 7.33 +3.28 +81.1% Sep 30, 2019
Q2 2019 4.96 -2.15 -30.2% Jun 30, 2019
Q1 2019 3.47 -9.89 -74% Mar 31, 2019
Q4 2018 2.65 -40.2 -93.8% Dec 31, 2018
Q3 2018 4.04 -61.8 -93.9% Sep 30, 2018
Q2 2018 7.11 -91.2 -92.8% Jun 30, 2018
Q1 2018 13.4 -128 -90.5% Mar 31, 2018
Q4 2017 42.8 -96.4 -69.2% Dec 31, 2017
Q3 2017 65.8 -68.2 -50.9% Sep 30, 2017
Q2 2017 98.4 -22.3 -18.5% Jun 30, 2017
Q1 2017 141 +772 Mar 31, 2017
Q4 2016 139 -10.4 -6.97% Dec 31, 2016
Q3 2016 134 +195 Sep 30, 2016
Q2 2016 121 +342 Jun 30, 2016
Q1 2016 -631 -639 -7919% Mar 31, 2016
Q4 2015 150 +140 +1415% Dec 31, 2015
Q3 2015 -60.5 -70.2 -724% Sep 30, 2015
Q2 2015 -221 -233 -2055% Jun 30, 2015
Q1 2015 8.07 -2.38 -22.8% Mar 31, 2015
Q4 2014 9.88 +0.9 +10% Dec 31, 2014
Q3 2014 9.7 -1.68 -14.8% Sep 30, 2014
Q2 2014 11.3 +0.69 +6.49% Jun 30, 2014
Q1 2014 10.5 -0.81 -7.19% Mar 31, 2014
Q4 2013 8.98 -11.2 -55.5% Dec 31, 2013
Q3 2013 11.4 -11 -49.1% Sep 30, 2013
Q2 2013 10.6 -23.6 -68.9% Jun 30, 2013
Q1 2013 11.3 -36.4 -76.4% Mar 31, 2013
Q4 2012 20.2 Dec 31, 2012
Q3 2012 22.4 Sep 30, 2012
Q2 2012 34.2 Jun 30, 2012
Q1 2012 47.6 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.